gabapentin has been researched along with ropinirole in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Happe, S; Klösch, G; Saletu, B; Sauter, C; Zeitlhofer, J | 1 |
| Allen, RP; Hening, W; Tenzer, P; Winkelman, JW | 1 |
| Anderer, P; Gruber, G; Nia, S; Parapatics, S; Saletu, B; Saletu, M; Saletu-Zyhlarz, GM | 1 |
| de Biase, S; Gigli, GL; Lorenzut, S; Merlino, G; Valente, M | 1 |
| Amos, LB; Collins, MM; D'Andrea, LA; Grekowicz, ML; Kuhn, EM; Norins, NA; Olstad, JD | 1 |
| Anderer, P; Saletu, B; Saletu-Zyhlarz, GM | 1 |
| Cho, YW; Jeon, JY; Lee, HB; Moon, HJ; Song, ML | 1 |
| Jankovic, J; Wijemanne, S | 1 |
| Jo, J; Mousa, SA; Sahli, ZT; Tarazi, FI | 1 |
| Ahmadouk, NA; Gopaluni, S; Sherif, M | 1 |
| Sinclair, PM | 1 |
| Hartzema, AG; Kim, J | 1 |
| Allen, RP; Earley, CJ; Foster, K; Hiranniramol, K; Skeba, P; Wang, A | 1 |
8 review(s) available for gabapentin and ropinirole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Restless legs syndrome: nonpharmacologic and pharmacologic treatments.
Topics: Amines; Anemia, Iron-Deficiency; Anticonvulsants; Benzothiazoles; Clonazepam; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ferritins; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Iron; Levodopa; Pramipexole; Restless Legs Syndrome; Trace Elements | 2007 |
ADMET considerations for restless leg syndrome drug treatments.
Topics: Amines; Anticonvulsants; Benzothiazoles; Carbamates; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ergolines; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Neuralgia; Pramipexole; Pregabalin; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2012 |
Recent advances in sleep research.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Amines; Antiparkinson Agents; Biomedical Research; Cyclohexanecarboxylic Acids; Databases, Factual; Europe; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Male; Mandibular Advancement; Mental Disorders; Middle Aged; Polysomnography; Psychometrics; Restless Legs Syndrome; Sex Distribution; Sleep Apnea Syndromes; Sleep Bruxism; Sleep Medicine Specialty; Sleep Wake Disorders; Snoring; Young Adult | 2013 |
Restless legs syndrome: clinical presentation diagnosis and treatment.
Topics: Amines; Analgesics, Opioid; Benzothiazoles; Cyclohexanecarboxylic Acids; Dopamine Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Methadone; Pramipexole; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2015 |
Clinical management of restless legs syndrome in end-stage renal disease patients.
Topics: Amines; Analgesics, Opioid; Benzodiazepines; Benzothiazoles; Comorbidity; Cyclohexanecarboxylic Acids; Dopamine Agonists; Excitatory Amino Acid Antagonists; Exercise Therapy; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Intermittent Pneumatic Compression Devices; Kidney Failure, Chronic; Levodopa; Massage; Pramipexole; Quality of Life; Renal Dialysis; Restless Legs Syndrome; Sleep Hygiene; Tetrahydronaphthalenes; Thiophenes | 2017 |
Interventions for chronic kidney disease-associated restless legs syndrome.
Topics: Amines; Anticonvulsants; Ascorbic Acid; Cyclohexanecarboxylic Acids; Dopamine Agonists; Exercise Therapy; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Iron-Dextran Complex; Levodopa; Quality of Life; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Renal Replacement Therapy; Resistance Training; Restless Legs Syndrome; Vitamin E; Vitamins | 2016 |
Interventions for chronic kidney disease-associated restless legs syndrome.
Topics: Exercise Therapy; Gabapentin; Humans; Indoles; Iron-Dextran Complex; Levodopa; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Restless Legs Syndrome; Vitamins | 2018 |
1 trial(s) available for gabapentin and ropinirole
| Article | Year |
|---|---|
Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome.
Topics: Acetates; Adult; Aged; Amines; Calcium Channel Blockers; Cross-Over Studies; Cyclohexanecarboxylic Acids; Dopamine Agonists; Drug Administration Schedule; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Male; Middle Aged; Pilot Projects; Polysomnography; Restless Legs Syndrome; Surveys and Questionnaires | 2003 |
7 other study(ies) available for gabapentin and ropinirole
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome.
Topics: Amines; Anti-Dyskinesia Agents; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Male; Mental Processes; Middle Aged; Placebos; Polysomnography; Psychometrics; Respiration; Restless Legs Syndrome; Single-Blind Method; Sleep; Sleep Stages; Sleep, REM; Time Factors; Treatment Outcome | 2010 |
Treatment of pediatric restless legs syndrome.
Topics: Adolescent; Amines; Analgesics; Anticonvulsants; Antioxidants; Benzothiazoles; Child; Child, Preschool; Clonidine; Cyclohexanecarboxylic Acids; Dopamine Agonists; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Iron; Male; Melatonin; Mental Disorders; Pediatrics; Polysomnography; Pramipexole; Restless Legs Syndrome; Retrospective Studies; Sleep Wake Disorders; Treatment Outcome | 2014 |
Augmentation in restless legs syndrome patients in Korea.
Topics: Aged; Aged, 80 and over; Amines; Benzothiazoles; Cross-Sectional Studies; Cyclohexanecarboxylic Acids; Disease Progression; Dopamine Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Korea; Long-Term Care; Male; Middle Aged; Pramipexole; Pregabalin; Restless Legs Syndrome; Risk Factors | 2015 |
Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analgesics; Dopamine Agonists; Female; Gabapentin; Humans; Indoles; Male; Medication Adherence; Middle Aged; Pramipexole; Restless Legs Syndrome; Retrospective Studies | 2018 |
Assessment of change in restless legs syndrome symptoms during the acute drug-withdrawal period.
Topics: Analgesics; Analgesics, Opioid; Dopamine Agonists; Electromyography; Female; Gabapentin; Humans; Indoles; Male; Middle Aged; Oxycodone; Polysomnography; Pramipexole; Restless Legs Syndrome; Substance Withdrawal Syndrome | 2018 |